Psychopharmacology for young children: Clinical needs and research opportunities

Benedetto Vitiello

Research output: Contribution to journalArticle

Abstract

In response to concerns about the increasing use of psychotropic medications in preschoolers, the National Institute of Mental Health and the Food and Drug Administration convened a workshop in October 2000 to examine the current state of knowledge regarding psychopharmacology for young children and discuss a variety of topics relevant to research in this age group, including safety, efficacy, investigational methods, and ethical aspects. The meeting gathered researchers, practitioners, ethicists, industry staff, and family and patient representatives. Efficacy and safety of psychotropics have not been systematically evaluated in preschoolers. The major limitation to this research is the diagnostic uncertainty surrounding most manifestations of psychopathology in early childhood. Research in developmental psychopathology is needed to clarify diagnosis and provide sensitive and specific methods for clinical trials. Possible approaches to expanding the research basis of this area of clinical practice, including a recently started study of methylphenidate in preschoolers, are reported here.

Original languageEnglish (US)
Pages (from-to)983-989
Number of pages7
JournalPediatrics
Volume108
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Psychopharmacology
Psychopathology
Research
Ethicists
National Institute of Mental Health (U.S.)
Patient Advocacy
Safety
Methylphenidate
United States Food and Drug Administration
Uncertainty
Industry
Age Groups
Research Personnel
Clinical Trials
Education

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Psychopharmacology for young children : Clinical needs and research opportunities. / Vitiello, Benedetto.

In: Pediatrics, Vol. 108, No. 4, 2001, p. 983-989.

Research output: Contribution to journalArticle

Vitiello, Benedetto. / Psychopharmacology for young children : Clinical needs and research opportunities. In: Pediatrics. 2001 ; Vol. 108, No. 4. pp. 983-989.
@article{93397233da4543b0b30574ee6667dd2c,
title = "Psychopharmacology for young children: Clinical needs and research opportunities",
abstract = "In response to concerns about the increasing use of psychotropic medications in preschoolers, the National Institute of Mental Health and the Food and Drug Administration convened a workshop in October 2000 to examine the current state of knowledge regarding psychopharmacology for young children and discuss a variety of topics relevant to research in this age group, including safety, efficacy, investigational methods, and ethical aspects. The meeting gathered researchers, practitioners, ethicists, industry staff, and family and patient representatives. Efficacy and safety of psychotropics have not been systematically evaluated in preschoolers. The major limitation to this research is the diagnostic uncertainty surrounding most manifestations of psychopathology in early childhood. Research in developmental psychopathology is needed to clarify diagnosis and provide sensitive and specific methods for clinical trials. Possible approaches to expanding the research basis of this area of clinical practice, including a recently started study of methylphenidate in preschoolers, are reported here.",
author = "Benedetto Vitiello",
year = "2001",
doi = "10.1542/peds.108.4.983",
language = "English (US)",
volume = "108",
pages = "983--989",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - Psychopharmacology for young children

T2 - Clinical needs and research opportunities

AU - Vitiello, Benedetto

PY - 2001

Y1 - 2001

N2 - In response to concerns about the increasing use of psychotropic medications in preschoolers, the National Institute of Mental Health and the Food and Drug Administration convened a workshop in October 2000 to examine the current state of knowledge regarding psychopharmacology for young children and discuss a variety of topics relevant to research in this age group, including safety, efficacy, investigational methods, and ethical aspects. The meeting gathered researchers, practitioners, ethicists, industry staff, and family and patient representatives. Efficacy and safety of psychotropics have not been systematically evaluated in preschoolers. The major limitation to this research is the diagnostic uncertainty surrounding most manifestations of psychopathology in early childhood. Research in developmental psychopathology is needed to clarify diagnosis and provide sensitive and specific methods for clinical trials. Possible approaches to expanding the research basis of this area of clinical practice, including a recently started study of methylphenidate in preschoolers, are reported here.

AB - In response to concerns about the increasing use of psychotropic medications in preschoolers, the National Institute of Mental Health and the Food and Drug Administration convened a workshop in October 2000 to examine the current state of knowledge regarding psychopharmacology for young children and discuss a variety of topics relevant to research in this age group, including safety, efficacy, investigational methods, and ethical aspects. The meeting gathered researchers, practitioners, ethicists, industry staff, and family and patient representatives. Efficacy and safety of psychotropics have not been systematically evaluated in preschoolers. The major limitation to this research is the diagnostic uncertainty surrounding most manifestations of psychopathology in early childhood. Research in developmental psychopathology is needed to clarify diagnosis and provide sensitive and specific methods for clinical trials. Possible approaches to expanding the research basis of this area of clinical practice, including a recently started study of methylphenidate in preschoolers, are reported here.

UR - http://www.scopus.com/inward/record.url?scp=0034790392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034790392&partnerID=8YFLogxK

U2 - 10.1542/peds.108.4.983

DO - 10.1542/peds.108.4.983

M3 - Article

C2 - 11581454

AN - SCOPUS:0034790392

VL - 108

SP - 983

EP - 989

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -